title: Conjunctival extranodal marginal zone B-cell lymphoma with crystal-storing histiocytosis.
authors.affiliation: Dalmia Ophthalmic Pathology Services, L.V. Prasad Eye Institute, Bhubaneswar, India.
authors.forename: Ruchi
authors.initials: R
authors.lastname: Mittal
authors.affiliation: Ocular Oncology Service, University of California, San Francisco, CA, USA.
authors.forename: Bertil
authors.initials: B
authors.lastname: Damato
authors.affiliation: Pathology, Department of Clinical and Molecular Cancer Medicine, University of Liverpool, Liverpool, UK.
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Coupland
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D003230:Conjunctival Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D003460:Crystallization; D003520:Cyclophosphamide / Q000627:therapeutic use; D015614:Histiocytosis / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use; D014792:Visual Acuity
chemical_list: D014408:Biomarkers, Tumor; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone